Bi-Specific MAbS Market Report 2030 Forecast
                     Bi-Specific MAbS Market Global Report 2020-30: 
Covid 19 Growth And Change
www.tbrc.info Email: [email protected] © The Business Research Company. All rights 
reserved.
Bi-Specific MAbS Market 
Characteristics:
• The global bi-specific MAbs market was valued at about $1.56 billion in 2019 and is expected to grow 
to $2.93 billion in 2020 at a compound annual growth rate (CAGR) of 87.6%. The COVID-19 
restrictions caused a slowdown in growth from 2018 due to missed patient visits affecting potential 
new patients who deferred the care, whereas existing patients remained on their treatment. 
However, with the sales beginning to recover slowly, the market is expected to stabilize and reach 
$6.12 billion by 2023 at a CAGR of 27.8%.
• The Business Research Company published its Bi-Specific MAbS Global Market Report 2020 which 
provides strategists, marketers and senior management with the critical information they need to 
assess the global Bi-Specific MAbS market. The report provides in-depth analysis of the impact of 
COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.
• The report covers the Bi-Specific MAbS market’s segments- 
• 1) By Type: Catumaxomab (Removab), Blinatumomab, Duligotumab, SAR 156597
• 2) By Product Type: In Vivo, In Vitro
• The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North 
America, South America, Middle East, and Africa. 
Click Here To View Complete Report
2 © The Business Research Company. All rights reserved.

Major Key Players:
Johnson & Johnson, 
Novartis AG, 
Hoffmann-La Roche Ltd., 
Novo Nordisk A/S, 
Bayer AG, 
Thermo Fisher Scientific, Inc., 
Bistro-Myers Squibb.
Click Here To Get A Sample Report
3 © The Business Research Company. All rights reserved.
Table Of Content 
1. Executive Summary
2. Report Structure
3. Bi-Specific MAbS Market Characteristics
4. Bi-Specific MAbS Market Product Analysis
5. Bi-Specific MAbS Market Supply Chain
……
26. Key Mergers And Acquisitions In The Bi-Specific MAbS Market
27. Bi-Specific MAbS Market Trends And Strategies
28. Bi-Specific MAbS Market Future Outlook and Potential Analysis
29. Appendix
     
  Click Here To Get A Sample Report
                              
          4                 The Business Research Company. All rights reserved.
Get In Touch
Whatever your need be, at The 
Business Research Company we 
provide research consulting solutions 
for businesses, government agencies 
consultancies, and market research 
companies.
5 © The Business Research Company. All rights reserved.
Europe Asia Americas
The Business Research Company The Business Research Company, The Business Research Company
47 Anchorage Point, Horizon Avenue, 625 South Avenue, Apt B204,
42 Cuba Street, Canary Wharf, 8-2-603/b/s/1/2 Secane, Philadelphia, PA 19018, 
London, England, Road Number 10 USA
E14 8NE. Banjara Hills +1 3156230293
+44 207 1930 708 Hyderabad (India) Email: [email protected]
Email: [email protected] 500033 www.tbrc.info
www.tbrc.info ++91 8897263534
Email: [email protected]
www.tbrc.info
6 © The Business Research Company. All rights reserved.